M. Buckley

发表

Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity.

K. Browman, Jill M. Wetter, G. Diaz, 2007, Biochemical pharmacology.

Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: Comparison with typical and atypical antipsychotics

P. Curzon, D. R. Britton, A. Nadzan, 1992, Pharmacology Biochemistry and Behavior.

(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.

D. Donnelly-roberts, J. Sullivan, D. Anderson, 1994, The Journal of pharmacology and experimental therapeutics.

Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H 3 Receptor Antagonist

Min Zhang, K. Browman, Jill M. Wetter, 2005 .

Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.

S. Arneric, J. Sullivan, D. Garvey, 1994, Journal of medicinal chemistry.

ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders.

D. Donnelly-roberts, G. Gintant, J. Sullivan, 2006, CNS drug reviews.

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.

S. Arneric, M. Decker, N. Lin, 1998, The Journal of pharmacology and experimental therapeutics.

Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.

Arianna Gelain, Daniela Barlocco, Lucio Toma, 2007, Journal of medicinal chemistry.

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.

D. Donnelly-roberts, S. Arneric, C. Briggs, 1998, Journal of medicinal chemistry.

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.

D. Donnelly-roberts, S. Arneric, J. Sullivan, 1998, Bioorganic & medicinal chemistry letters.

Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.

S. Arneric, M. Decker, N. Lin, 1998, European journal of pharmacology.

A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models.

T. Dyhring, K. Marsh, C. Faltynek, 2007, Biochemical pharmacology.

Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties.

A. D. Rodrigues, D. Donnelly-roberts, S. Arneric, 1997, Journal of medicinal chemistry.

2-(Aryloxymethyl) azacyclic analogues as novel nicotinic acetylcholine receptor (nAChR) ligands

S. Arneric, J. Sullivan, D. Garvey, 1996 .

An open‐label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101

G. Wittert, R. Harrison, M. Buckley, 2016, Andrology.

Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

Min Zhang, K. Browman, Jill M. Wetter, 2005, Journal of Pharmacology and Experimental Therapeutics.

Aminopyridazine muscarinic agonist, SR 95639A, is a functional M2 receptor antagonist in rat brain

E. Cadman, M. Williams, M. Decker, 1991 .

Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists.

R. Henry, T. Dyhring, C. Surowy, 2006, Journal of medicinal chemistry.

Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test.

M. Day, Rachel L Navarra, J. Sullivan, 2007, Biochemical pharmacology.

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.

J. Sullivan, J. L. Raszkiewicz, J. Brioni, 1994, The Journal of pharmacology and experimental therapeutics.

Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo

W. J. Jackson, D. Donnelly-roberts, S. Arneric, 1997, Pharmacology Biochemistry and Behavior.

Pharmacological Properties of ABT-239: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

K. Browman, Jill M. Wetter, R. Porsolt, 2004 .

Effects of histamine H3 receptor antagonists in two models of spatial learning

K. Browman, M. Decker, G. Fox, 2005, Behavioural Brain Research.

Mechanism of action of A-85380 in an animal model of depression

M. Meyer, C. Surowy, P. Curzon, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia.

K. Browman, J. Sullivan, M. E. Ballard, 2005, Inflammation Research.

Linopirdine (DuP996) facilitates the retention of avoidance training and improves performance of septal-lesioned rats in the water maze

S. Arneric, J. Brioni, M. Decker, 1993, Pharmacology Biochemistry and Behavior.

Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.

S. Arneric, J. Brioni, M. Decker, 1994, The Journal of pharmacology and experimental therapeutics.

Histaminergic mechanisms in the CNS Selective H 3 receptor ( H 3 R ) blockade : broad efficacy in cognition and schizophrenia

K. Browman, J. Sullivan, M. E. Ballard, 2022 .

ABT — 418, a Novel Nicotinic Agonist

A. D. Rodrigues, W. J. Jackson, Y. Martin, 1994 .